Troy Drewry is also the President of MB Innovations and has over 17 years of successful product development and project management experience with notable accomplishments in the design and development of novel instruments and implant systems and numerous orthopedic medical device inventions. Drewry was most recently VP US Operations for Paradigm Spine and earlier served with Active Implants Corporation as COO. In February of 1995, Mr. Drewry began his product development career at Medtronic Sofamor Danek (NYSE: MDT), based in Memphis, Tenn. Drewry received his Bachelor’s and Master’s Degrees in Mechanical and Biomedical Engineering at University of Louisiana-Lafayette and University of Memphis, respectively. He also holds a Master’s in Engineering Management from Christian Brothers University.
Jack is currently a Biological engineering student at North Carolina State University and Co-inventor of Surgilight. Jack has worked over 4 years in the medical device industry as a contract engineer for over 12 companies including Spinewave and Medtown Ventures. Jack has been involved with start-ups and design initiation from topics ranging from spinal implants to robotics, and continues to facilitate entrepreneurial endeavors. Jack has contributed to 5 filed US patents and continues to invest effort into developing novel medical device concepts. Jack currently works as a design engineer at EG-Gilero in Durham, a company specializing in medical and drug delivery device product development.
Gary Stevenson co-founded MB Venture Partners in 2001 after six years in health care investment banking and research. He also spent seven years in a variety of general management roles with Abbott Laboratories, one of the largest and most diversified health care companies in the world. Gary holds an undergraduate degree in accounting from the University of Missouri. He also received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University. He is a certified public accountant and a chartered financial analyst. Gary is a board member or observer for several MBVP portfolio companies including AxioMed Spine, BioSET, Kereos, KFx Medical, Hapten Sciences, S2 Interactive, Visioneering, Focal Point Pharmaceuticals, iScreen, Restore Medical Solutions, MB Innovations, EcoSurg, View Medical, Better Walk, Camplex, and CrossRoads. Gary also serves on the board of Life Science Tennessee and ZeroTo510.
Mike Sherman Board Member
Mike Sherman has been a Partner at MB Venture Partners since September 2006 after 16 years at Memphis-based Medtronic Sofamor Danek (MSD), a subsidiary of Medtronic (NYSE: MDT). Mike spent his first nine years at Sofamor Danek building the product portfolio by developing and commercializing several key product lines. In 1999, he assumed the position of Vice President of Technology Development, where his responsibilities included directing a product development team focused on minimally invasive and motion preserving solutions as well as technical and business due diligence on acquisitions, in-licensing activities, and strategic investments. Prior to Sofamor Danek, Mike held positions at Synthes and Richards Medical. Over the course of his career, Mike has amassed over 100 issued US patents on various inventions. Mike received his Bachelor of Science in Biomedical Engineering from Rensselaer Polytechnic Institute and a Master of Science in Biomedical Engineering from the University of Texas, Southwestern Graduate School. He serves on the Board of Directors for Anulex Technologies, Cayenne Medical, Calosyn Pharma, Expanding Orthopedics, Hubble Telemedical, Tidal Wave Technology, Veracity Medical, Urova Medical, Nanopthalmics, Innometrix, EndoInsight and Zyga Technology and is Chairman of the Board for MB Innovations.
Mark Augusti is Integra’s Corporate Vice President, and President of Orthopedics and Tissue Technologies. Mr. Augusti is responsible for the management of the Orthopedics and Tissue Technologies global division which includes spine and extremity implants, orthobiologics, tissue products, and the Private Label business. His responsibilities include U.S. commercial leadership, global portfolio management, evaluation of corporate development opportunities and overall strategic direction. He joined Integra in April 2014 as Corporate Vice President and President of Orthopedics and Tissue Technologies, and brings over 25 years of executive management experience in medical technology. Prior to joining Integra, Mr. Augusti served as Chief Executive Officer at Bioventus LLC, from May 2012 to August 2013, and was a member of the company’s Board of Directors during the same period. Prior to that Mr. Augusti spent nine years with Smith & Nephew, from April 2003 to April 2012, in a series of leadership roles, including President of Smith & Nephew’s Biologic Division, where he was appointed to lead Smith & Nephew’s new biologics initiative. He also served as Smith & Nephew’s President of the Orthopaedic Trauma & Clinical Therapies Global Business and Senior Vice President and General Manager of the Trauma business. Prior to that, from1987 to 2000, he spent 13 years at GE Medical Systems, where he held various sales, marketing and strategic management roles, both in the U.S. and internationally. Mr. Augusti received his M.B.A. from the UCLA Anderson School of Management, and his B.S. in Computer Science and Economics from Duke University.
Dr. Boyd is President of Palmetto Biomedical and serves as a Director with Medtown Ventures. He is an international leader in medical device innovation, with over 60 issued U.S. patents for medical devices and related procedures. He is an experienced business leader & manager, with a 25 year career leading product development, engineering and business development efforts around medical devices. Dr. Boyd had an extensive career with Medtronic Sofamor Danek, starting with the post-IPO Danek Medical in 1992 to the acquisition by Medtronic, with positions of increasing responsibility, culminating in worldwide product development leadership position for the Interbody Division. He is an experienced product development leader with experience spanning a cross-functional global medical device business.
After receiving his BS degree in Mechanical Engineering and MS degree in Bioengineering from Clemson University in 1989, he became product development group leader and engineer at Dow Corning Wright in Arlington, TN, and during his three years there, developed implants for use in hands, feet, and knees. He then moved on to work for a small start-up company in Memphis that at the time was called Danek Medical (later Sofamor Danek). The company’s focus was in an emerging arena for medical implants, spinal fusion. Dr. Boyd worked in the area of interbody fusion and artificial disc replacement.
He held positions of manager, director and group director, where he focused his efforts on research, development and commercialization of medical technologies. To further his leadership skills, he also enrolled in a Master of Engineering Management program at Christian Brothers University. Medtronic later acquired Sofamor Danek and promoted him to vice president of product development.
Recognizing the growing importance of recombinant proteins, human tissues and other biologically inspired materials and potential for applications to spine, he started on his PhD in Biomedical Engineering at Duke University in 2000. Dr. Boyd received his PhD in the summer of 2007, and accepted a position as Associate Director of the Center for Entrepreneurship and Research Commercialization at Duke. In addition, Dr. Boyd was an adjunct professor for the Biomedical Engineering Department and the Masters of Engineering Management Program at Duke. He is the Founder and President of Palmetto Biomedical, Inc. He is also a co-founder of two medical device ventures, View Medical and Orthoclip.